Literature DB >> 18095643

2,3-dihydro-6,7-dihydroxy-1H-isoindol-1-one-based HIV-1 integrase inhibitors.

Xue Zhi Zhao1, Elena A Semenova, B Christie Vu, Kasthuraiah Maddali, Christophe Marchand, Stephen H Hughes, Yves Pommier, Terrence R Burke.   

Abstract

The bis-salicylhydrazides class of HIV-1 integrase (IN) inhibitors has been postulated to function by metal chelation. However, members of this series exhibit potent inhibition only when Mn2+ is used as cofactor. The current study found that bis-aroylhydrazides could acquire inhibitory potency in Mg2+ using dihydroxybenzoyl substituents as both the right and left components of the hydrazide moiety. Employing a 2,3-dihydro-6,7-dihydroxy-1 H-isoindol-1-one ring system as a conformationally constrained 2,3-dihydroxybenzoyl equivalent provided good selectivity for IN-catalyzed strand transfer versus the 3'-processing reactions as well as antiviral efficacy in cells using HIV-1 based vectors.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18095643     DOI: 10.1021/jm070715d

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  24 in total

1.  Development of tricyclic hydroxy-1H-pyrrolopyridine-trione containing HIV-1 integrase inhibitors.

Authors:  Xue Zhi Zhao; Kasthuraiah Maddali; Mathieu Metifiot; Steven J Smith; B Christie Vu; Christophe Marchand; Stephen H Hughes; Yves Pommier; Terrence R Burke
Journal:  Bioorg Med Chem Lett       Date:  2011-03-21       Impact factor: 2.823

2.  MK-0536 inhibits HIV-1 integrases resistant to raltegravir.

Authors:  Mathieu Métifiot; Barry Johnson; Steven Smith; Xue Zhi Zhao; Christophe Marchand; Terrence Burke; Stephen Hughes; Yves Pommier
Journal:  Antimicrob Agents Chemother       Date:  2011-08-29       Impact factor: 5.191

3.  6,7-Dihydroxy-1-oxoisoindoline-4-sulfonamide-containing HIV-1 integrase inhibitors.

Authors:  Xue Zhi Zhao; Kasthuraiah Maddali; Steven J Smith; Mathieu Métifiot; Barry C Johnson; Christophe Marchand; Stephen H Hughes; Yves Pommier; Terrence R Burke
Journal:  Bioorg Med Chem Lett       Date:  2012-10-27       Impact factor: 2.823

4.  A homology model of HIV-1 integrase and analysis of mutations designed to test the model.

Authors:  Barry C Johnson; Mathieu Métifiot; Andrea Ferris; Yves Pommier; Stephen H Hughes
Journal:  J Mol Biol       Date:  2013-03-27       Impact factor: 5.469

5.  Developing and Evaluating Inhibitors against the RNase H Active Site of HIV-1 Reverse Transcriptase.

Authors:  Paul L Boyer; Steven J Smith; Xue Zhi Zhao; Kalyan Das; Kevin Gruber; Eddy Arnold; Terrence R Burke; Stephen H Hughes
Journal:  J Virol       Date:  2018-06-13       Impact factor: 5.103

6.  Structural and functional analyses of the second-generation integrase strand transfer inhibitor dolutegravir (S/GSK1349572).

Authors:  Stephen Hare; Steven J Smith; Mathieu Métifiot; Albert Jaxa-Chamiec; Yves Pommier; Stephen H Hughes; Peter Cherepanov
Journal:  Mol Pharmacol       Date:  2011-06-30       Impact factor: 4.436

7.  Comparison of metal-dependent catalysis by HIV-1 and ASV integrase proteins using a new and rapid, moderate throughput assay for joining activity in solution.

Authors:  Mark D Andrake; Joseph Ramcharan; George Merkel; Xue Zhi Zhao; Terrence R Burke; Anna Marie Skalka
Journal:  AIDS Res Ther       Date:  2009-06-29       Impact factor: 2.250

8.  Selectivity for strand-transfer over 3'-processing and susceptibility to clinical resistance of HIV-1 integrase inhibitors are driven by key enzyme-DNA interactions in the active site.

Authors:  Mathieu Métifiot; Barry C Johnson; Evgeny Kiselev; Laura Marler; Xue Zhi Zhao; Terrence R Burke; Christophe Marchand; Stephen H Hughes; Yves Pommier
Journal:  Nucleic Acids Res       Date:  2016-07-01       Impact factor: 16.971

Review 9.  6,7-Dihydroxyisoindolin-1-one and 7,8-Dihydroxy-3,4-Dihydroisoquinolin- 1(2H)-one Based HIV-1 Integrase Inhibitors.

Authors:  Xue Zhi Zhao; Mathieu Metifiot; Steven J Smith; Kasthuraiah Maddali; Christophe Marchand; Stephen H Hughes; Yves Pommier; Terrence R Burke
Journal:  Curr Top Med Chem       Date:  2016       Impact factor: 3.295

10.  Examination of halogen substituent effects on HIV-1 integrase inhibitors derived from 2,3-dihydro-6,7-dihydroxy-1H-isoindol-1-ones and 4,5-dihydroxy-1H-isoindole-1,3(2H)-diones.

Authors:  Xue Zhi Zhao; Kasthuraiah Maddali; B Christie Vu; Christophe Marchand; Stephen H Hughes; Yves Pommier; Terrence R Burke
Journal:  Bioorg Med Chem Lett       Date:  2009-03-28       Impact factor: 2.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.